Connect with us
The president of Atrys Health gave a positive assessment of the 2021 financial year, in which the company launched the takeover bid for Aspy, various acquisitions...
In ten years since its inception, Moderna has transformed from a research-stage company advancing programs in the messenger RNA (mRNA) field to a company with a...
The Spanish biotech company AcceXible has recently entered the market in Colombia. AcceXible expects to have a turnover of $491,000 (€450,000) in 2022. The company received...
Moderna closed 2021 with a profit of $12.2 billion, compared to a loss of $747 million recorded in 2020. Moderna's total revenue in 2021 was $18.471...
For the time being, Devicare is launching this product in the Netherlands. At the beginning of 2021, Devicare closed a financing round of $3 million. The...
GenesisCare has more than 350 oncology centers around the world. The works have meant a great qualitative leap forward, equipping the Alcázar de San Juan center...
The six listed pharmaceutical companies close the first quarter of 2022 with a stock market value of $16.7 billion (€15.1 billion). The biggest decline was registered...
The Spanish company Exheus has recently opened a financing round in order to launch into the European market. The functioning of Exheus tests is based on...
Integra Therapeutics will allocate the funds to the development of the FiCAT platform prototype and preclinical validation. The Catalan company has also raised sufficient capital to...
The capital raised by Kither Biotech will be used to fund the development of Kither's lead product (Kit2014), a novel cell-permeable peptide for the treatment of...
 |
|
 |  |
 |
|